source
- Novartis' Rhapsido shows safety edge and relapse reduction in Phase 3 multiple sclerosis trialsNovartis reported results from two identical Phase 3 studies of its BTK inhibitor Rhapsido in patients with multiple sclerosis. The trials showed the oral pill lowered the annualized relapse rate…
- Medtronic recalls Bravo CF reflux monitoring capsule after 184 serious injuries reportedMedtronic has issued a recall of its Bravo CF esophageal pH monitoring capsule, a wireless device used to assess acid reflux. The recall follows an FDA early alert after the company identified a pr…